SIHUAN PHARM (00460.HK) -0.040 (-2.759%) Short selling $7.55M; Ratio 54.367% announced its annual results for the year ended 31 December 2025, with a turnover of RMB2.618 billion, up 37.7% YoY. Profit amounted to RMB180 million, representing a turnaround from a loss of RMB217 million in the same period of 2024.
AASTOCKS Financial News